CAR-T细胞治疗-话题@MedSci

#CAR-T细胞治疗#

28篇内容 | 4374人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2238286, encodeId=4ada22382865e, content=<a href='/topic/show?id=a07f82814ec' target=_blank style='color:#2F92EE;'>#肿瘤免疫治疗#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>, objectTitle=CAR-T、CAR-NK和CAR-M，各有什么优缺点？, objectType=article, longId=851544, objectId=cb8c851544e4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/conference-with-doctors-in-medical-aprons-PT29AAG.jpg, objectUrl=/article/show_article.do?id=cb8c851544e4, replyNumber=0, likeNumber=15, createdTime=2024-11-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=cb8c851544e4, moduleTitle=CAR-T、CAR-NK和CAR-M，各有什么优缺点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb8c851544e4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231124, encodeId=a36922311242e, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=edba4069ec' target=_blank style='color:#2F92EE;'>#CAR-T治疗#</a> <a href='/topic/show?id=d5131100e823' target=_blank style='color:#2F92EE;'>#急性髓系白血病（AML）#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>, objectTitle=J Transl Med：赵明峰教授团队探索CLL1 CAR-T治疗髓外病变AML的疗效和安全性, objectType=article, longId=847108, objectId=9dc084e1083f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20241011/ce9c365ddb3048bc8abb7768d52d5ed6-5QGvA9BRKW6q.jpg, objectUrl=/article/show_article.do?id=9dc084e1083f, replyNumber=0, likeNumber=67, createdTime=2024-10-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=9dc084e1083f, moduleTitle=J Transl Med：赵明峰教授团队探索CLL1 CAR-T治疗髓外病变AML的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dc084e1083f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2229308, encodeId=0ae12229308a6, content=<a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>, objectTitle=JAMA Oncol：CAR-T细胞治疗晚期结直肠癌获突破，OS达到26.1个月, objectType=article, longId=845864, objectId=6cce84586464, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20241004/1a4d085372224de4a2f637990c3039b9-hYhpk7ZeASWQ.jpg, objectUrl=/article/show_article.do?id=6cce84586464, replyNumber=0, likeNumber=67, createdTime=2024-10-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=6cce84586464, moduleTitle=JAMA Oncol：CAR-T细胞治疗晚期结直肠癌获突破，OS达到26.1个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cce84586464)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225607, encodeId=2dbf222560e96, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=aed6822267' target=_blank style='color:#2F92EE;'>#GPRC5D#</a>, objectTitle=BJH：杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效, objectType=article, longId=843103, objectId=0286843103aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240913/8e1f8c541ef74b3b87d1d3f8bd730228-kdyoX2gTLsR5.jpg, objectUrl=/article/show_article.do?id=0286843103aa, replyNumber=0, likeNumber=68, createdTime=2024-09-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=0286843103aa, moduleTitle=BJH：杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0286843103aa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221312, encodeId=95c12221312c6, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=6ec61050e7b0' target=_blank style='color:#2F92EE;'>#RRMM#</a>, objectTitle=【柳叶刀血液学】BCMA/GPRC5D双特异性CAR-T细胞治疗RRMM的I期研究, objectType=article, longId=839469, objectId=6a6e8394699b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720669414779_5579292.png, objectUrl=/article/show_article.do?id=6a6e8394699b, replyNumber=0, likeNumber=160, createdTime=2024-08-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6a6e8394699b, moduleTitle=【柳叶刀血液学】BCMA/GPRC5D双特异性CAR-T细胞治疗RRMM的I期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a6e8394699b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2217914, encodeId=33dd221e91428, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=36a511e4136e' target=_blank style='color:#2F92EE;'>#CAR-E#</a>, objectTitle=Nat Biotech：一种新型的CAR-E技术有望永久攻克肿瘤, objectType=article, longId=837087, objectId=042f83e087ec, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240729/68e08a4800f7461c920fcc51c9b021a8-V7nkEkCkuA7t.jpg, objectUrl=/article/show_article.do?id=042f83e087ec, replyNumber=0, likeNumber=79, createdTime=2024-08-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=042f83e087ec, moduleTitle=Nat Biotech：一种新型的CAR-E技术有望永久攻克肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=042f83e087ec)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216459, encodeId=20e7221645980, content=<a href='/topic/show?id=247743555b6' target=_blank style='color:#2F92EE;'>#大B细胞淋巴瘤#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=c0ad429356' target=_blank style='color:#2F92EE;'>#CD22#</a>, objectTitle=柳叶刀发表CD22 CAR-T治疗CAR19失败的LBCL的I期研究，新的希望即将来临？, objectType=article, longId=835565, objectId=bd9683556534, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240719/1721377067764_92910.png, objectUrl=/article/show_article.do?id=bd9683556534, replyNumber=0, likeNumber=61, createdTime=2024-07-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bd9683556534, moduleTitle=柳叶刀发表CD22 CAR-T治疗CAR19失败的LBCL的I期研究，新的希望即将来临？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd9683556534)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214146, encodeId=61d32214146cf, content=<a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=e640838971' target=_blank style='color:#2F92EE;'>#H3K27M#</a> <a href='/topic/show?id=1639116459ed' target=_blank style='color:#2F92EE;'>#弥散性中线神经胶质瘤#</a> <a href='/topic/show?id=4ea211646009' target=_blank style='color:#2F92EE;'>#IL7受体#</a>, objectTitle=JCO：C7R-GD2.CAR-T细胞治疗恶性脑瘤一期临床试验结果, objectType=article, longId=830578, objectId=e3d28305e854, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720160262047_5579292.jpg, objectUrl=/article/show_article.do?id=e3d28305e854, replyNumber=0, likeNumber=120, createdTime=2024-07-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e3d28305e854, moduleTitle=JCO：C7R-GD2.CAR-T细胞治疗恶性脑瘤一期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3d28305e854)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2213634, encodeId=f435221363467, content=<a href='/topic/show?id=567650039e9' target=_blank style='color:#2F92EE;'>#弥漫大B细胞淋巴瘤#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=99c2116323a4' target=_blank style='color:#2F92EE;'>#继发肿瘤#</a>, objectTitle=NEJM：CAR-T细胞治疗继发肿瘤风险可控, objectType=article, longId=830412, objectId=d6f0830412f9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240706/1720278226555_5579292.png, objectUrl=/article/show_article.do?id=d6f0830412f9, replyNumber=0, likeNumber=83, createdTime=2024-07-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d6f0830412f9, moduleTitle=NEJM：CAR-T细胞治疗继发肿瘤风险可控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6f0830412f9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211801, encodeId=cd62221180112, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=62d2e6828cc' target=_blank style='color:#2F92EE;'>#糖皮质激素#</a> <a href='/topic/show?id=e0d7546812c' target=_blank style='color:#2F92EE;'>#托珠单抗#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>, objectTitle=【BCJ】多发性骨髓瘤CAR-T治疗后使用糖皮质激素和托珠单抗不影响预后, objectType=article, longId=831719, objectId=e167831e19a9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240625/1719325400715_5579292.jpg, objectUrl=/article/show_article.do?id=e167831e19a9, replyNumber=0, likeNumber=106, createdTime=2024-06-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e167831e19a9, moduleTitle=【BCJ】多发性骨髓瘤CAR-T治疗后使用糖皮质激素和托珠单抗不影响预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e167831e19a9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211097, encodeId=09e7221109e42, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>, objectTitle=JCO：北京大学齐长松团队发现CAR-T细胞治疗胰腺癌，疾病控制率达70.8%, objectType=article, longId=831113, objectId=a8e58311139d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240621/14a08651aa804b93a703f8cad708f9c3-6zM00RdjbxtO.jpg, objectUrl=/article/show_article.do?id=a8e58311139d, replyNumber=0, likeNumber=157, createdTime=2024-06-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=a8e58311139d, moduleTitle=JCO：北京大学齐长松团队发现CAR-T细胞治疗胰腺癌，疾病控制率达70.8%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8e58311139d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208739, encodeId=f1482208e391d, content=<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=50a510662947' target=_blank style='color:#2F92EE;'>#CLDN18.2#</a>, objectTitle=Nat med：科济药业CAR-T疗法CT041治疗CLDN18.2阳性胃癌疗效显著！96.1%疾病控制率！, objectType=article, longId=829076, objectId=dc428290e663, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240529/f7b2056d9d644c84a9056c99d711fcaa-YPQIVAdq7NcK.jpg, objectUrl=/article/show_article.do?id=dc428290e663, replyNumber=0, likeNumber=103, createdTime=2024-06-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=dc428290e663, moduleTitle=Nat med：科济药业CAR-T疗法CT041治疗CLDN18.2阳性胃癌疗效显著！96.1%疾病控制率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc428290e663)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201009, encodeId=f8f4220100980, content=<a href='/topic/show?id=70e6139138a' target=_blank style='color:#2F92EE;'>#PD-1抑制剂#</a> <a href='/topic/show?id=634d90542d9' target=_blank style='color:#2F92EE;'>#西达本胺#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=a80f10e3046' target=_blank style='color:#2F92EE;'>#LBCL#</a>, objectTitle=Int Immunopharmacol：LBCL CAR-T后西达本胺和PD1维持治疗可改善预后, objectType=article, longId=823683, objectId=fe51823683d5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PTE4SCK.jpg, objectUrl=/article/show_article.do?id=fe51823683d5, replyNumber=0, likeNumber=150, createdTime=2024-04-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe51823683d5, moduleTitle=Int Immunopharmacol：LBCL CAR-T后西达本胺和PD1维持治疗可改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe51823683d5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200789, encodeId=f1022200e89ec, content=对复发或难治性CD7阳性<a href='/topic/show?id=1991e1775c9' target=_blank style='color:#2F92EE;'>#白血病#</a>或<a href='/topic/show?id=970e659640a' target=_blank style='color:#2F92EE;'>#淋巴瘤#</a>患者，序贯<a href='/topic/show?id=8c1510460960' target=_blank style='color:#2F92EE;'>#CD7#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>和单倍体同种HSCT治疗，而不需要药理学骨髓消融或GVHD预防，这篇研究可以入选2024年<a href='/topic/show?id=ae41356995a' target=_blank style='color:#2F92EE;'>#十大#</a>，也是我国<a href='/topic/show?id=6d9f113892a3' target=_blank style='color:#2F92EE;'>#血液病学#</a>领域的重大研究成果。为后续其它类型的白血病的治疗提供新的思路。, objectTitle=NEJM：浙江大学黄河团队合作开发CAR T新方案，成功治疗难治性白血病, objectType=article, longId=823365, objectId=1e0882336503, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894910506_4754896.jpeg, objectUrl=/article/show_article.do?id=1e0882336503, replyNumber=0, likeNumber=150, createdTime=2024-04-27, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=1e0882336503, moduleTitle=NEJM：浙江大学黄河团队合作开发CAR T新方案，成功治疗难治性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e0882336503)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2198377, encodeId=9e0221983e73f, content=<a href='/topic/show?id=f7603e0370d' target=_blank style='color:#2F92EE;'>#原发性中枢神经系统淋巴瘤#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>, objectTitle=Am. J. Hematol：CAR T细胞治疗在复发原发性中枢神经系统淋巴瘤患者中显示出较高的长期缓解率, objectType=article, longId=821500, objectId=4111821500ba, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240413/1713020059241_6145188.png, objectUrl=/article/show_article.do?id=4111821500ba, replyNumber=0, likeNumber=145, createdTime=2024-04-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4111821500ba, moduleTitle=Am. J. Hematol：CAR T细胞治疗在复发原发性中枢神经系统淋巴瘤患者中显示出较高的长期缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4111821500ba)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197670, encodeId=35e0219e670d2, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=48b742e03ce' target=_blank style='color:#2F92EE;'>#复杂性尿路感染#</a>, objectTitle=‘四大顶刊’一周研究导读：关于减肥药利弊的最新证据；CD19 CAR-T细胞治疗自身免疫性疾病疗效显著；“最常见”乳腺癌的新策略；头孢吡肟-他尼硼巴坦治疗复杂性尿路感染；, objectType=article, longId=820924, objectId=0f638209249d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221201/1669967667900_4754896.jpeg, objectUrl=/article/show_article.do?id=0f638209249d, replyNumber=0, likeNumber=112, createdTime=2024-04-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0f638209249d, moduleTitle=‘四大顶刊’一周研究导读：关于减肥药利弊的最新证据；CD19 CAR-T细胞治疗自身免疫性疾病疗效显著；“最常见”乳腺癌的新策略；头孢吡肟-他尼硼巴坦治疗复杂性尿路感染；, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f638209249d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197104, encodeId=a0f3219e1040b, content=<a href='/topic/show?id=257ae692755' target=_blank style='color:#2F92EE;'>#系统性红斑狼疮#</a> <a href='/topic/show?id=787ae6923db' target=_blank style='color:#2F92EE;'>#系统性硬化症#</a> <a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=3b17113112f4' target=_blank style='color:#2F92EE;'>#特发性炎性肌炎#</a>, objectTitle=NEJM：CD19 CAR-T细胞治疗自身免疫性疾病疗效显著！, objectType=article, longId=820351, objectId=28d3820351fc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240403/42845980022e4189b79ed0ab709ee723-xqKNhN6Awx3N.jpg, objectUrl=/article/show_article.do?id=28d3820351fc, replyNumber=0, likeNumber=120, createdTime=2024-04-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=28d3820351fc, moduleTitle=NEJM：CD19 CAR-T细胞治疗自身免疫性疾病疗效显著！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28d3820351fc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2191997, encodeId=0865219199e46, content=<a href='/topic/show?id=4e2640e283' target=_blank style='color:#2F92EE;'>#CAR-T细胞#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=970e659640a' target=_blank style='color:#2F92EE;'>#淋巴瘤#</a>, objectTitle=Nature：淋巴瘤中CARD11-PIK3R3突变，让CAR-T细胞抗癌能力提高百倍, objectType=article, longId=816075, objectId=e9548160e5b5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240305/82df5f0ac3e94b7bac3a71b4a78b9acb-F5zkyiEvGX00.jpg, objectUrl=/article/show_article.do?id=e9548160e5b5, replyNumber=0, likeNumber=88, createdTime=2024-03-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=e9548160e5b5, moduleTitle=Nature：淋巴瘤中CARD11-PIK3R3突变，让CAR-T细胞抗癌能力提高百倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9548160e5b5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184226, encodeId=12df218422620, content=<a href='/topic/show?id=16db1105910c' target=_blank style='color:#2F92EE;'>#ALPL-1#</a>是<a href='/topic/show?id=251e10183059' target=_blank style='color:#2F92EE;'>#骨肉瘤#</a><a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>疗法新<a href='/topic/show?id=07a69996557' target=_blank style='color:#2F92EE;'>#靶点#</a>, objectTitle=Nature子刊：研究发现ALPL-1是骨肉瘤CAR-T疗法新靶点, objectType=article, longId=788891, objectId=851fe8889156, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=851fe8889156, replyNumber=0, likeNumber=88, createdTime=2024-01-27, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=851fe8889156, moduleTitle=Nature子刊：研究发现ALPL-1是骨肉瘤CAR-T疗法新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=851fe8889156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2180717, encodeId=2b782180e174a, content=<a href='/topic/show?id=170699e5621' target=_blank style='color:#2F92EE;'>#非霍奇金淋巴瘤#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=921a385567' target=_blank style='color:#2F92EE;'>#B细胞非霍奇金淋巴瘤#</a>, objectTitle=Mol Cancer：新型CAR-T细胞治疗AT101治疗复发或难治性B细胞非霍奇金淋巴瘤，客观缓解率91.7%！, objectType=article, longId=808750, objectId=a96d808e5065, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240110/c78414aa3c734f5c83af23aff25a5873.jpg, objectUrl=/article/show_article.do?id=a96d808e5065, replyNumber=0, likeNumber=121, createdTime=2024-01-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=a96d808e5065, moduleTitle=Mol Cancer：新型CAR-T细胞治疗AT101治疗复发或难治性B细胞非霍奇金淋巴瘤，客观缓解率91.7%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a96d808e5065)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

CAR-T细胞治疗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肿瘤免疫治疗# #CAR-T细胞治疗#

CAR-T、CAR-NK和CAR-M，各有什么优缺点？

2024-11-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#AML# #CAR-T治疗# #急性髓系白血病（AML）# #CAR-T细胞治疗#

J Transl Med：赵明峰教授团队探索CLL1 CAR-T治疗髓外病变AML的疗效和安全性

2024-10-16发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#结直肠癌# #CAR-T细胞治疗#

JAMA Oncol：CAR-T细胞治疗晚期结直肠癌获突破，OS达到26.1个月

2024-10-05发表于加利福尼亚

梅斯管理员 (审核中...)

前往app查看评论内容

#二甲双胍# #CAR-T细胞治疗# #GPRC5D#

BJH：杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效

2024-09-13发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #CAR-T细胞治疗# #RRMM#

【柳叶刀血液学】BCMA/GPRC5D双特异性CAR-T细胞治疗RRMM的I期研究

2024-08-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肿瘤# #CAR-T细胞治疗# #CAR-E#

Nat Biotech：一种新型的CAR-E技术有望永久攻克肿瘤

2024-08-01发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#大B细胞淋巴瘤# #CAR-T细胞治疗# #CD22#

柳叶刀发表CD22 CAR-T治疗CAR19失败的LBCL的I期研究，新的希望即将来临？

2024-07-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#CAR-T细胞治疗# #H3K27M# #弥散性中线神经胶质瘤# #IL7受体#

JCO：C7R-GD2.CAR-T细胞治疗恶性脑瘤一期临床试验结果

2024-07-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#弥漫大B细胞淋巴瘤# #CAR-T细胞治疗# #继发肿瘤#

NEJM：CAR-T细胞治疗继发肿瘤风险可控

2024-07-06发表于上海

梅斯管理员 (审核中...)